Revolution Medicines, Inc. Warrant (RVMDW)
Market Closed
20 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
1. 88
-6.33
-77.1011%
$
39.27B Market Cap
- P/E Ratio
- Div Yield
20,221 Volume
- Eps
$ 8.21
Previous Close Investors:
Want to track RVMDW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Revolution Medicines, Inc. Warrant (RVMDW) Statistics
Valuation metrics
Market Cap 39.27B
Enterprise value 39.57B
Trailing P/E (ttm) -26.18
Forward P/E -
PEG ratio 0.54
Price/Sales (ttm) -
Price/Book (mrq) 24.59
Enterprise Value/Revenue -
Enterprise Value/EBITDA -30.01
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 25.65K
Average volume (90 days) 110.89K
Price summary
52-Week low 0.16
52-Week high 10
Beta -
50-Day moving average 9.13
200-Day moving average 2.91
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.61%
Return on equity -0.83%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.92
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.29
Current ratio (mrq) 6.8%
Book value per share (mrq) 7.57
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
